1. Home
  2. AROW vs FDMT Comparison

AROW vs FDMT Comparison

Compare AROW & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

N/A

Current Price

$38.13

Market Cap

727.1M

Sector

Finance

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$11.88

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AROW
FDMT
Founded
1851
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
727.1M
695.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
AROW
FDMT
Price
$38.13
$11.88
Analyst Decision
Hold
Strong Buy
Analyst Count
4
12
Target Price
★ $43.50
$28.09
AVG Volume (30 Days)
54.5K
★ 971.2K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
★ 3.10%
N/A
EPS Growth
★ 49.72
18.79
EPS
★ 1.48
N/A
Revenue
N/A
★ $85,209,000.00
Revenue This Year
$24.57
N/A
Revenue Next Year
$16.41
$55.65
P/E Ratio
$26.20
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$28.00
$6.96
52 Week High
$42.70
$16.93

Technical Indicators

Market Signals
Indicator
AROW
FDMT
Relative Strength Index (RSI) 55.92 44.00
Support Level $37.23 $8.68
Resistance Level $40.13 $11.96
Average True Range (ATR) 0.86 0.94
MACD 0.21 0.04
Stochastic Oscillator 75.42 44.43

Price Performance

Historical Comparison
AROW
FDMT

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: